| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tropical Metabolism Research Unit (M.S.B., M.T., F.I.B., T.E.F.), Tropical Medicine Research Institute, The University of the West Indies, Mona, Kingston 7, Jamaica; Medical Research Council Environmental Epidemiology Unit (C.O.), University of Southampton, Southampton General Hospital, Southampton, United Kingdom SO16 6YD; and Department of Medicine (J.P.M.), Kings College School of Medicine and Dentistry, London, United Kingdom SE5 9PJ
Address all correspondence and requests for reprints to: Prof. Terrence E. Forrester, Tropical Metabolism Research Unit, Tropical Medicine Research Institute, The University of the West Indies, Mona, Kingston 7, Jamaica. E-mail: tesgf{at}mail.infochan.com.
Fetal IGF-I is a determinant of birth weight, but whether maternal IGF-I plays a significant role is controversial. We sought to examine the relationships among maternal IGF-I, IGF-binding protein (IGFBP)-1, and IGFBP-2, with maternal and newborn anthropometry, in a cohort of 325 nondiabetic pregnant women of African origin. Blood was collected for IGF-I, IGFBP-1, and IGFBP-2 at 9, 25, and 35 wk gestation and in cord blood at delivery.
In the second and third trimesters, maternal IGF-I was significantly correlated (P < 0.005) with maternal body mass index and triceps skinfold thickness. Maternal IGFBP-1 and -2 had an inverse correlation (P < 0.0001), with maternal anthropometry. Maternal IGF-I at 35 wk, and fetal IGF-I by cord blood were significantly correlated with birth weight (P = 0.001 and 0.048, respectively). IGFBP-1 in the third trimester and cord blood were negatively correlated with birth weight (P = 0.012 and 0.002). In multiple regression analyses, maternal IGF-I at 35 wk, fetal IGF-I, maternal weight at the first antenatal visit, gender, and gestational age were significant independent factors in the determination of birth weight. In conclusion, maternal IGF-I levels, especially during late pregnancy, positively influence birth weight.
Abbreviations: BMI, Body mass index; CV, coefficient(s) of variation; IGFBP, IGF-binding protein.
This article has been cited by other articles:
![]() |
E. Milne, J. A. Royle, N. H. de Klerk, E. Blair, H. Bailey, C. Cole, J. Attia, R. J. Scott, and B. K. Armstrong Fetal Growth and Risk of Childhood Acute Lymphoblastic Leukemia: Results From an Australian Case-Control Study Am. J. Epidemiol., July 15, 2009; 170(2): 221 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
W Ricart, J Lopez, J Mozas, A Pericot, M A Sancho, N Gonzalez, M Balsells, R Luna, A Cortazar, P Navarro, et al. Maternal glucose tolerance status influences the risk of macrosomia in male but not in female fetuses J Epidemiol Community Health, January 1, 2009; 63(1): 64 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S Schernhammer, S. S Tworoger, A H. Eliassen, S. A Missmer, J. M Holly, M. N Pollak, and S. E Hankinson Body shape throughout life and correlations with IGFs and GH Endocr. Relat. Cancer, September 1, 2007; 14(3): 721 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Troisi, N. Potischman, and R. N. Hoover Exploring the Underlying Hormonal Mechanisms of Prenatal Risk Factors for Breast Cancer: A Review and Commentary Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1700 - 1712. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Milne, C. L. Laurvick, E. Blair, C. Bower, and N. de Klerk Fetal Growth and Acute Childhood Leukemia: Looking Beyond Birth Weight Am. J. Epidemiol., July 15, 2007; 166(2): 151 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ben Lagha, D. Seurin, Y. Le Bouc, M. Binoux, A. Berdal, P. Menuelle, and S. Babajko Insulin-Like Growth Factor Binding Protein (IGFBP-1) Involvement in Intrauterine Growth Retardation: Study on IGFBP-1 Overexpressing Transgenic Mice Endocrinology, October 1, 2006; 147(10): 4730 - 4737. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shankar, M. Hidestrand, X. Liu, R. Xiao, C. M. Skinner, F. A. Simmen, T. M. Badger, and M. J. J. Ronis Physiologic and Genomic Analyses of Nutrition-Ethanol Interactions During Gestation: Implications for Fetal Ethanol Toxicity Experimental Biology and Medicine, September 1, 2006; 231(8): 1379 - 1397. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Murphy, R. Smith, W. B. Giles, and V. L. Clifton Endocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus Endocr. Rev., April 1, 2006; 27(2): 141 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ross High Birthweight and Cancer: Evidence and Implications Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 1 - 2. [Full Text] [PDF] |
||||
![]() |
T. Radaelli, J. Uvena-Celebrezze, J. Minium, L. Huston-Presley, P. Catalano, and S. Hauguel-de Mouzon Maternal Interleukin-6: Marker of Fetal Growth and Adiposity Reproductive Sciences, January 1, 2006; 13(1): 53 - 57. [Abstract] [PDF] |
||||
![]() |
M. Manikkam, E. J. Crespi, D. D. Doop, C. Herkimer, J. S. Lee, S. Yu, M. B. Brown, D. L. Foster, and V. Padmanabhan Fetal Programming: Prenatal Testosterone Excess Leads to Fetal Growth Retardation and Postnatal Catch-Up Growth in Sheep Endocrinology, February 1, 2004; 145(2): 790 - 798. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |